160 related articles for article (PubMed ID: 35708074)
1. AGAP2-AS1: An Indispensable lncRNA in Tumors.
Chen J; Wang B
Mini Rev Med Chem; 2023; 23(3):336-342. PubMed ID: 35708074
[TBL] [Abstract][Full Text] [Related]
2. LncRNA AGAP2-AS1 augments cell viability and mobility, and confers gemcitabine resistance by inhibiting miR-497 in colorectal cancer.
Hong S; Yan Z; Song Y; Bi M; Li S
Aging (Albany NY); 2020 Mar; 12(6):5183-5194. PubMed ID: 32202509
[TBL] [Abstract][Full Text] [Related]
3. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
[TBL] [Abstract][Full Text] [Related]
4. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
Chen J; Peng X; Dai Y
Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
7. AGAP2-AS1 promotes the assembly of m6A methyltransferases and activation of the IL6/STAT3 pathway by binding with WTAP in the carcinogenesis of gastric cancer.
Nie K; Zheng Z; Li J; Chang Y; Deng Z; Huang W; Li X
FASEB J; 2023 Dec; 37(12):e23302. PubMed ID: 37983949
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma.
Ren P; Niu X; Zhao R; Liu J; Ren W; Dai H; Chen J; Yan J; Li B; Shao Y; Bai Y; Han P
Cell Cycle; 2022 Apr; 21(7):697-707. PubMed ID: 35113007
[TBL] [Abstract][Full Text] [Related]
9. RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4.
Hui B; Ji H; Xu Y; Wang J; Ma Z; Zhang C; Wang K; Zhou Y
Cell Death Dis; 2019 Feb; 10(3):207. PubMed ID: 30814490
[TBL] [Abstract][Full Text] [Related]
10. EIF4A3 stabilizes the expression of lncRNA AGAP2-AS1 to activate cancer-associated fibroblasts via MyD88/NF-κb signaling.
Xu Q; Zhao T; Han H; Fan J; Xie W
Thorac Cancer; 2023 Feb; 14(5):450-461. PubMed ID: 36541122
[TBL] [Abstract][Full Text] [Related]
11. E2F4-induced AGAP2-AS1 up-regulation accelerates the progression of colorectal cancer via miR-182-5p/CFL1 axis.
Guo Z; Liu X; Shao H
Dig Liver Dis; 2022 Jul; 54(7):878-889. PubMed ID: 34838479
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
Zheng Y; Lu S; Xu Y; Zheng J
Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
[TBL] [Abstract][Full Text] [Related]
14. lncRNA AGAP2-AS1 Facilitates Tumorigenesis and Ferroptosis Resistance through SLC7A11 by IGF2BP2 Pathway in Melanoma.
An L; Huang J; Ge S; Zhang X; Wang J
Comput Math Methods Med; 2022; 2022():1972516. PubMed ID: 35707044
[TBL] [Abstract][Full Text] [Related]
15. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic roles and mechanisms of lncRNA AGAP2-AS1 in human solid tumors.
Bao Z; Zheng Q; Li L
Am J Transl Res; 2021; 13(2):757-769. PubMed ID: 33594324
[TBL] [Abstract][Full Text] [Related]
17. AGAP2-AS1 serves as an oncogenic lncRNA and prognostic biomarker in glioblastoma multiforme.
Tian Y; Zheng Y; Dong X
J Cell Biochem; 2019 Jun; 120(6):9056-9062. PubMed ID: 30525219
[TBL] [Abstract][Full Text] [Related]
18. SP1 induced long non-coding RNA AGAP2-AS1 promotes cholangiocarcinoma proliferation via silencing of CDKN1A.
Ji H; Wang J; Lu B; Li J; Zhou J; Wang L; Xu S; Peng P; Hu X; Wang K
Mol Med; 2021 Feb; 27(1):10. PubMed ID: 33522895
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA AGAP2-AS1 promotes proliferation and metastasis in papillary thyroid cancer by miR-628-5p/KLF12 axis.
Xu C; Shao Y; Liu J; Yao X; Quan F; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Bai Y; Zheng Z; Zhang S
J Bioenerg Biomembr; 2021 Apr; 53(2):235-245. PubMed ID: 33604734
[TBL] [Abstract][Full Text] [Related]
20. Down-regulated lncRNA AGAP2-AS1 contributes to pre-eclampsia as a competing endogenous RNA for JDP2 by impairing trophoblastic phenotype.
Xu Y; Xia X; Jiang Y; Wu D; Wang S; Fu S; Yang N; Zhang Y; Sun L
J Cell Mol Med; 2020 Apr; 24(8):4557-4568. PubMed ID: 32150333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
